- home
- about us
- Investment Approach
- Client Service Approach
- Market Analysis Summary
- Mission Statement
- Value Proposition
- Team Biographies
- Firm ADV PDFs
- Form CRS
- Firm Brochure-Part 2A of Form ADV
- Brochure Supplement Amit Stavinsky
- Brochure Supplement Frank Parks
- Brochure Supplement Dominick Savo
- Brochure Supplement Richard Mason
- Brochure Supplement Joe Estes
- Brochure Supplement Jonathan Ezra
- Statement Of Financial Strength
- Job Opportunities
- Letter to Clients
- member log-in
- contact us
Latest News about Pablo Zuanic
Recent news which mentions Pablo Zuanic
Tilray Vs. Canopy Growth: Which Cannabis Stock Deserves Premium Valuation? Analyst Opines
April 28, 2022
From Benzinga
This Cannabis Retailer Is Poised To Grow Top-Line Despite Tough Environment, Analyst Explains Why
April 27, 2022
From Benzinga
From Benzinga
What To Focus On Now After Tilray's Q3 Earnings Report, Analyst Shares Main Takeaways
April 07, 2022
Tickers
TLRY
From Benzinga
Curaleaf Holdings To Report Q1 Results In Anticipation Of New Jersey Legal Cannabis Launch
April 06, 2022
Tickers
CURLF
From Benzinga
Jushi's Earnings Power Is Evolving But This Analyst Remains Sidelined, At Least For Now
March 29, 2022
Tickers
JUSHF
From Benzinga
Why Is Trulieve Still Among Top Cannabis Stock Picks? Analyst's Thoughts Ahead Of Q4 Earnings
March 29, 2022
From Benzinga
From Benzinga
Analyst on Charlotte's Web: 'We Stay Neutral, But Do Keep An Eye On This CBD Sector Bellwether Stock'
March 25, 2022
From Benzinga
When Will New Jersey's Recreational Marijuana Sales Begin? What's Next After Another Delay?
March 25, 2022
Tickers
CURLF
From Benzinga
From Benzinga
Pharmacist Managing Billion Dollar Cannabis-Focused Fund, Jason Wild Of TerrAscend: Meet Our Keynote Speakers
March 23, 2022
From Benzinga
From Benzinga
Analyst Is Warming Up To This Cannabis Stock As It Reports Q1 Earnings & Successful Shift To Discount Model
March 18, 2022
Tickers
HITI
From Benzinga
Why Federal Cannabis Legalization Is 'A Question Of When, Not If,' Says Canopy Growth CEO: Meet Our Keynote Speakers
March 15, 2022
From Benzinga
An American Success Story, Cannabis Mogul Boris Jordan Of Curaleaf: Meet Our Keynote Speakers
March 11, 2022
From Benzinga
Pricing Pressure, Illegal Cannabis Products – Curaleaf And GTI Explain Impacts On Their Earnings
March 07, 2022
From Benzinga
Is Village Farms Positioned For Business Growth Despite Revenue Drop? Analyst Opines Post Q4 Earnings
March 07, 2022
Tickers
VFF
From Benzinga
Is It Time To Invest In Curaleaf? Analyst Says 'Use The Pullback' As The Stock Has Upside Potential
March 04, 2022
From Benzinga
From Benzinga
Brief Thoughts Ahead Of 4Q For Curaleaf Holdings: New Jersey Could Be Next Main Catalyst
February 26, 2022
From Benzinga
WM Technology Shares Skyrocket, Analyst Says The Stock Looks Attractive
February 24, 2022
Tickers
MAPS
From Benzinga
This Is The Hidden Upside Driver For Canopy Growth's Stock, According To A Leading Analyst
February 18, 2022
From Benzinga
Will Aleafia Reach Its Revenue Goals With Convertible Debt Being 'Pushed Back'? Analyst's Thoughts Post Q4 Earnings
February 18, 2022
Tickers
ALEAF
From Benzinga
Analyst: Dissecting Marijuana Sales Growth And Cannabis Dispensary Performance in Florida
February 16, 2022
From Benzinga
Will Aurora Bounce Back? Analyst Explains Why The Stock Is A 'Long-Term Turnaround Story'
February 11, 2022
From Benzinga
Canopy Growth Shares Are Trading Higher Today, Analysts Tell Us Why
February 09, 2022
Tickers
CGC
From Benzinga
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.